(Reuters) – Walgreens Boots Alliance (NASDAQ:) agreed to pay $106.8 million to settle fees it billed the U.S. authorities for prescriptions that have been by no means disbursed, the Division of Justice stated on Friday.
The Justice Division stated that from 2009 to 2020, Walgreens submitted false claims for cost to Medicare, Medicaid and different federal well being care packages for prescriptions it processed however which have been by no means picked up.